COSCIENS Biopharma Inc.
CSCIF- Exchange
- OTC
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- SEC CIK
- 0001113423
No open-market purchases or sales by COSCIENS Biopharma Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in COSCIENS Biopharma Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +7 vs. Q3 2024
- Shares held
- 21.0K
- +4.31K (+25.8%) vs. Q3 2024
- Total value
- $56.9K
- −$5.00K (−8.1%) vs. Q3 2024
- New holders
- 8
- 2 more added
- Sold out
- 1
- 1 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CSCIF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $10.3K |
| Q2 2025 | 15 | $104.5K |
| Q1 2025 | 15 | $77.0K |
| Q4 2024 | 15 | $56.9K |
| Q3 2024 | 9 | $61.9K |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding COSCIENS Biopharma Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| National Bank of Canada | 5,920 | $15.9K | 0.00% | +124+2.1% | Added |
| Royal Bank of Canada | 3,936 | $11.0K | 0.00% | +1,409+55.8% | Added |
| Federation des caisses Desjardins du Quebec | 3,873 | $10.3K | 0.00% | −663−14.6% | Reduced |
| TD Waterhouse Canada Inc. | 3,717 | $9.94K | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 1,151 | $3.09K | 0.00% | +1,151 | New |
| Citigroup Inc | 902 | $2.42K | 0.00% | +902 | New |
| UBS Group AG | 686 | $1.90K | 0.00% | +686 | New |
| Morgan Stanley | 400 | $1.11K | 0.00% | +400 | New |
| SBI Securities Co., Ltd. | 165 | $457 | 0.00% | +165 | New |
| BNP Paribas Arbitrage, SA | 100 | $271 | 0.00% | +100 | New |
| Advisor Group Holdings, Inc. | 50 | $134 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 38 | $105 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 37 | $100 | 0.00% | +37 | New |
| Truvestments Capital LLC | 22 | $61 | 0.00% | 00.0% | Unchanged |
| Groupe la Francaise | 1 | $8 | 0.00% | +1 | New |
| Danske Bank A/S | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Planning Capital Management Corp | – | – | – | – | Not filed |